Amoxicillin Dosing for Pneumonia in Adults
For community-acquired pneumonia in adults, amoxicillin should be dosed at 1 gram orally every 8 hours (3 grams total daily), not the lower standard doses of 250-500 mg three times daily. 1
Outpatient Treatment Regimens
Otherwise Healthy Adults (No Comorbidities)
- Amoxicillin 1 g orally every 8 hours as monotherapy is the recommended regimen for previously healthy adults with community-acquired pneumonia 1, 2
- This high-dose regimen provides adequate coverage even against drug-resistant Streptococcus pneumoniae (DRSP) despite lacking activity against atypical organisms 1
- The FDA-approved adult dosing range is 750 to 1750 mg/day in divided doses every 8 to 12 hours 3
Adults with Comorbidities
- For patients with comorbidities (cardiopulmonary disease, diabetes, chronic kidney/liver disease, immunosuppression, or age ≥65 years), amoxicillin 1 g every 8 hours must be combined with a macrolide (azithromycin 500 mg daily or clarithromycin 500 mg twice daily) 1, 2
- This combination addresses the risk of mixed infections with atypical organisms (Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella) which are common in this population 1
Alternative Beta-Lactam Option
- Amoxicillin-clavulanate 2000/125 mg twice daily can substitute for amoxicillin when beta-lactamase-producing organisms (H. influenzae, M. catarrhalis) are suspected 1
- This formulation provides enhanced coverage while maintaining the high amoxicillin dose needed for pneumococcal coverage 1
Hospitalized Patients (Non-Severe)
- For non-severe inpatients, use a beta-lactam plus macrolide combination: ampicillin-sulbactam 1.5-3 g every 6 hours, cefotaxime 1-2 g every 8 hours, or ceftriaxone 1-2 g daily PLUS azithromycin 500 mg daily or clarithromycin 500 mg twice daily 4
- Note that amoxicillin oral formulation is typically not the preferred beta-lactam for hospitalized patients requiring parenteral therapy 4
Treatment Duration
- Treat for 5-7 days in patients demonstrating clinical improvement 1
- Treatment should not routinely exceed 8 days in responding patients 1
- For severe pneumonia without identified pathogens, extend duration to 10 days 2
Critical Dosing Pitfalls to Avoid
Underdosing Risk
- Never use standard-dose amoxicillin (250-500 mg three times daily) for pneumonia, as this underdosing increases treatment failure risk and promotes antimicrobial resistance 1
- The high-dose regimen (1 g every 8 hours) is essential for achieving adequate serum and tissue concentrations against pneumococcal strains 5
Inappropriate Monotherapy
- Amoxicillin monotherapy should not be used in patients with comorbidities without adding atypical coverage, as mixed infections are common in this population 1
- Macrolide monotherapy should be avoided in areas with pneumococcal macrolide resistance ≥25%, but amoxicillin remains effective 1, 2
Recent Antibiotic Exposure
- Switch to a different antibiotic class if the patient received amoxicillin within the past 3 months to reduce resistance risk 1, 2
- This applies to any recent beta-lactam exposure, not just amoxicillin specifically 2
Contraindications and Limitations
- Amoxicillin should not be used for suspected MRSA or Pseudomonas aeruginosa pneumonia, as these require alternative coverage 1
- History of serious hypersensitivity reactions (anaphylaxis, Stevens-Johnson syndrome) to amoxicillin or other beta-lactams is an absolute contraindication 3
- For patients not improving on initial amoxicillin therapy, add or substitute a macrolide to cover atypical pathogens 2